Previous Studies
Moderna 1273
Omicron BA.1 – containing mRNA 1273 boosters compared with the original Covid-19 vaccine in the UK : a randomised, observer blind, active controlled trial
Background/Overview
The Omicron BA.1 bivalent booster is used globally . Previous open label studies of the Omicron BA.1 booster showed superior antibody response compared with the original mRNA 1273 booster . This study aims to compare the safety and immune response from the Omicron Boosters ( monovalent and bivalent) with the original MRNA-1273 vaccine in a large randomised control trial
Eagle 2
A new antibiotic for the treatment of uncomplicated Urinary Tract Infection ( UTI) in female adults and adolescents sponsored by GSK .
Uncomplicated Urinary Tract Infections are the most common outpatient infection with over half of all women developing a UTI during their lifetime and more than a quarter of women suffering recurrent UTIs.
Efficacy of AReSVi Vaccine in the Prevention of Respiratory Synctital Virus Types A and B
RSV is a common contagious virus affecting the lungs and breathing passages. It is one of the major remaining infectious diseases for which there is currently no vaccine or specific treatment.
LightHouse
The purpose of this study was to collect blood samples and medical information to help develop and evaluate a blood test that can screen for many cancers, including but not limited to lung, colorectal, ovarian, pancreatic, liver, bladder, stomach and oesophageal cancer from a single blood sample collection.
